A forum for researchers, students and applicants in the field of cyclodextrin technology
Background and purpose: Despite its contradictory clinical performance, Veklury® (remdesivir) has a pivotal role in COVID-19 therapy. Possible contributions of the
Remdesivir has emerged as a promising antiviral drug against SARS-CoV-2. However, data regarding the clinical benefits of remdesivir in patients
In the annual report of NASA there is a great recognition of benefits of cyclodextrin technology even in space chemistry.
In terms of solubilization effect, it was found that phase solubility of RDV increased significantly from intrinsic 1.7 mmol/L at
There were 648 patients enrolled in the study (216 cases and 432 controls). Viral clearance (VC) was observed in 490
In terms of solubilization effect, it was found that phase solubility of RDV increased significantly from intrinsic 1.7 mmol/L at
As remdesivir, the first FDA-approved drug for SARS-CoV-2 infection, can be used only for hospitalized patients due to intravenous administration,
The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal
The press release was published on the U.S. Food and Drug Administration website: On Apr. 26, 2022, the U.S. Food
The aim of this report is to review the literature and shed light on the uncertainties surrounding the use of
